The departure of the most senior scientific role in the European Commission has caused dismay among academics.
On 13 November, it emerged that there are no immediate plans to replace Anne Glover, who finished her term as chief scientific adviser to the Commission president on 31 October. UK researchers have raised concerns that Jean-Claude Juncker, the Commission’s president, does not value the importance of the CSA or attach sufficient weight to science advice.
According to Mark Downs, the chief executive of the Society of Biology: “This sends a signal that science and its role in policy-making has been downgraded at a time when Europe needs to do all it can to support innovation through an effective, realist and evidence-led policy and regulatory framework.”